Reach us directly, we respond to every message personally
Clinical research on NAD+ therapy has primarily used intravenous infusions at high doses (5001,000 mg) for applications such as addiction treatment and acute metabolic support [2] [9]
PubMed Klicek, R., Kolenc, D., Suran, J., Drmic, D., Brcic, L., Aralica, G., Sever, M., Holjevac, J., Radic, B., Turudic, T., Kokot, A., Patrlj, L., Rucman, R., Seiwerth, S., & Sikiric, P
These opioid receptors are distributed in central and peripheral nervous systems, gastrointestinal tract, immune cells, and some other tissues
The success rate of P-Shot injections can vary, as individual results may depend on age, overall health, and lifestyle choices